Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Virus Diseases × ledipasvir, sofosbuvir drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hepatitis C 2 Waldenstrom Macroglobulinemia 1 Virus Diseases 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Liver Diseases 1 Hepatitis C, Chronic 1

Interventions

ledipasvir, sofosbuvir drug combination 1 VP-102 1 Therapies, Investigational 1 Imiquimod 1 Gels 1 Cantharidin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02868242 2020-03-02

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Gilead Sciences

Phase 2 Completed

19 enrolled 14 charts

Hepatitis C, Liver Diseases, Virus Diseases, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡